Biotin anti-mouse TER-119/Erythroid Cells Antibody

Pricing & Availability
Clone
TER-119 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-76
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
TER-119_Biotin_TER-119_Antibody_FC_041713
C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
  • TER-119_Biotin_TER-119_Antibody_FC_041713
    C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
Compare all formats
Cat # Size Price Save
116203 50 µg ¥10,340
116204 500 µg ¥29,040
Description

The TER-119 antigen is a 52 kD glycophorin A-associated protein, also known as Ly-76. TER-119 is an erythroid-specific antigen expressed on early proerythroblasts to mature erythrocytes, but not on erythroid colony-forming cells (BFU-E, blast-forming unit erythroid, or CFU-E, colony-forming unit erythroid).

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References

(PubMed link indicates BioLegend citation)
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  4. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  5. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  6. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  7. Wu J, et al. 2022. Nat Commun. 13:7321. PubMed
  8. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  9. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  10. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  11. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  12. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  13. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  14. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  15. Geiger SS, et al. 2021. Nature Communications. 12(1):2745. PubMed
  16. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  17. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  18. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  19. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  20. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  21. Tian M, et al. 2020. Proc Natl Acad Sci U S A. 117:7929. PubMed
  22. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  23. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  24. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  25. Fu R, et al. 2019. Nat Commun. 10:3210. PubMed
  26. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  27. Hodzic D, et al. 2022. PLoS Biol. 20:e3001811. PubMed
  28. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  29. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  30. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  31. Iturri L, et al. 2021. Immunity. . PubMed
  32. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  33. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  34. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  35. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  36. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  37. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  38. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  39. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  40. Verena Sigl et al. 2017. Cell research. 26(7):761-74 . PubMed
  41. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  42. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  43. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  44. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  45. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  46. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  47. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  48. Liu YY, et al. 2020. Chin Med J (Engl). 133:1688. PubMed
  49. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  50. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  51. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  52. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  53. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  54. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  55. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  56. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  57. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  58. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  59. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  60. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  61. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  62. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  63. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  64. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  65. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  66. Peraki I, Palis J, and Mavrothalassitis G. 2017. Mol Cell Biol. 10.1128/MCB.00183-17. PubMed
  67. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  68. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  69. Dong S, et al. 2021. Nature. 591:117. PubMed
  70. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  71. Zhu H, et al. 2020. J Bone Miner Res. 35:698. PubMed
  72. Chatterjee S, et al. 2014. PLoS One. 9:87858. PubMed
  73. Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
  74. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  75. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  76. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  77. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  78. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  79. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  80. Sitaraman S, et al. 2019. Sci Rep. 9:12509. PubMed
  81. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  82. Lüönd F, et al. 2022. STAR Protoc. 3:101438. PubMed
  83. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  84. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  85. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  86. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  87. Wang C, et al. 2018. J Clin Invest. 128:3872. PubMed
  88. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  89. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  90. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  91. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  92. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  93. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  94. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  95. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  96. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  97. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  98. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  99. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  100. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  101. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  102. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  103. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  104. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  105. Gu VW, et al. 2021. Stem Cell Reports. 16:106. PubMed
  106. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  107. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  108. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  109. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  110. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  111. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  112. Buffolo M, et al. 2019. Cell Rep. 29:270. PubMed
  113. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  114. Hasenberg M, et al. 2011. PLoS One. 6:e17314. PubMed
  115. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  116. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  117. Alexander K, et al. 2016. Immunol Cell Biol. 95:7-16. PubMed
  118. Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed
  119. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  120. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  121. Wolock SL, et al. 2019. Cell Rep. 28:302. PubMed
  122. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  123. Koide S, et al. 2022. iScience. 25:103603. PubMed
  124. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  125. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  126. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  127. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  128. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  129. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  130. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  131. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  132. Michel A, et al. 2013. J Immunol. 90:5534. PubMed
  133. Lefkopoulos S, et al. 2020. Immunity. 53(5):934-951.e9. PubMed
  134. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  135. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  136. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  137. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  138. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  139. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  140. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  141. Huang X, et al. 2021. Immunity. . PubMed
  142. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  143. Seong J, et al. 2018. Development. 145:14. PubMed
  144. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  145. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  146. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  147. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  148. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  149. Young K, et al. 2021. Cell Stem Cell. . PubMed
  150. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
RRID
AB_313704 (BioLegend Cat. No. 116203)
AB_313705 (BioLegend Cat. No. 116204)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID
UniProt
View information about TER-119 on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All TER-119 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse TER-119/Erythroid Cells TER-119 FC
Biotin anti-mouse TER-119/Erythroid Cells TER-119 FC
FITC anti-mouse TER-119/Erythroid Cells TER-119 FC
PE anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB
Alexa Fluor® 488 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 647 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 700 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP/Cyanine5.5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 421™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Pacific Blue™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 650™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 510™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 605™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells (Maxpar® Ready) TER-119 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 785™ anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-A0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
APC/Fire™ 750 anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-B0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
TotalSeq™-C0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
Ultra-LEAF™ Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB,CMCD
Spark Blue™ 550 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Fire™ 810 anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark NIR™ 685 anti-mouse TER-119/Erythroid Cells Antibody TER-119 FC
Brilliant Violet 711™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Go To Top Version: 3    Revision Date: 12/04/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account